Consensus $6.60. Raises FY25 revenue view to at least $400M from at least $397.3B, consensus $399B. Raises FY25 adjusted operating income guidance view to $14.22B-$14.39B from $14.14B-$14.31B. “CVS Health (CVS) is committed to being the most trusted health care company in America,” said President and CEO, David Joyner. “We are executing with discipline, strengthening our core businesses and delivering meaningful progress across our enterprise. As we look ahead, we are focused on building a simpler, more connected and more affordable health care experience for consumers, health care professionals, and payors, delivering value for all stakeholders.” At Investor Day, CVS Health will update its 2025 full-year financial guidance.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- Cantor Fitzgerald says CMS guidance reinforces 2026 as ‘difficult for Medicaid’
- Republican lawmakers have yet to agree on healthcare plan, WSJ reports
- CVS Health price target raised to $86 from $77 at Bernstein
- Tesla’s Crowd of Investors Starting to Thin Out, According to New Data
- Jakks Pacific announces new licensing partnership with The Hershey Company